Literature DB >> 20605463

A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis.

Aaron Tan1, Neil Shuey, Christopher Bladin.   

Abstract

Two cases initially diagnosed as "encephalitis lethargica" are discussed. Both cases satisfied the published diagnostic criteria for encephalitis lethargica, with neuropsychiatric features including complex movement disorder, hypoventilation and altered conscious state. On later investigation N-methyl-D-aspartate receptor antibodies were detected in both cases. With the recent descriptions of tumour related antibodies to neuronal surface antigens in NMDA-receptor encephalitis, we highlight the importance of revisiting a diagnosis which may have prognostic significance. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605463     DOI: 10.1016/j.jocn.2010.01.010

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

2.  Progressive mental status changes and seizures with fluid attenuated inversion recovery (FLAIR) hyperintensity on brain MRI.

Authors:  Erick Tarula; Shakti Ramkissoon; Sean Pittock; Volney L Sheen
Journal:  J Clin Neurosci       Date:  2012-06       Impact factor: 1.961

3.  Understanding anti-IgLON5 disease.

Authors:  Francesc Graus; Joan Santamaría
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-08-24

4.  Encephalitis lethargica epidemic milestones in early sleep neurobiology researches.

Authors:  M da Mota Gomes
Journal:  Sleep Med       Date:  2020-08-26       Impact factor: 3.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.